$2.29
+0.05 (+2.23%)
Open$2.27
Previous Close$2.24
Day High$2.32
Day Low$2.20
52W High$28.75
52W Low$1.79
Volume—
Avg Volume112.9K
Market Cap13.02M
P/E Ratio—
EPS$-46.92
SectorBiotechnology
Analyst Ratings
Strong Buy
9 analysts
Price Target
+1,010.5% upside
Current
$2.29
$2.29
Target
$25.43
$25.43
$14.54
$25.43 avg
$32.33
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 2.53M | 2.25M | 2.34M |
| Net Income | -604,093 | -536,841 | -566,432 |
| Profit Margin | -23.9% | -23.9% | -24.2% |
| EBITDA | -828,287 | -680,626 | -721,197 |
| Free Cash Flow | -326,986 | -310,260 | -424,378 |
| Rev Growth | -6.1% | -2.1% | -7.6% |
| Debt/Equity | 0.51 | 0.64 | 0.68 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $214.87 | -1.20% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $354.05 | +0.63% | 24.7 | 190.40B |
| GILD | Gilead Sciences Inc | $140.73 | +0.98% | 19.6 | 166.66B |
| VRTX | Vertex Pharmaceuticals Inc | $449.71 | +0.71% | 29.1 | 114.87B |
| REGN | Regeneron Pharmaceuticals | $776.21 | +0.46% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $330.03 | -0.25% | 139.7 | 43.84B |